ATE527542T1 - Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie - Google Patents

Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie

Info

Publication number
ATE527542T1
ATE527542T1 AT06751892T AT06751892T ATE527542T1 AT E527542 T1 ATE527542 T1 AT E527542T1 AT 06751892 T AT06751892 T AT 06751892T AT 06751892 T AT06751892 T AT 06751892T AT E527542 T1 ATE527542 T1 AT E527542T1
Authority
AT
Austria
Prior art keywords
imaging probe
candidate
library
click chemistry
identifying
Prior art date
Application number
AT06751892T
Other languages
English (en)
Inventor
Hartmuth Kolb
Vani Mocharla
Joseph Walsh
Original Assignee
Siemens Medical Solutions
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Medical Solutions filed Critical Siemens Medical Solutions
Application granted granted Critical
Publication of ATE527542T1 publication Critical patent/ATE527542T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT06751892T 2005-04-27 2006-04-27 Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie ATE527542T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67529005P 2005-04-27 2005-04-27
PCT/US2006/016428 WO2006116736A2 (en) 2005-04-27 2006-04-27 A method for the preparation of imaging probes using click chemistry

Publications (1)

Publication Number Publication Date
ATE527542T1 true ATE527542T1 (de) 2011-10-15

Family

ID=36954603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06751892T ATE527542T1 (de) 2005-04-27 2006-04-27 Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie

Country Status (9)

Country Link
US (1) US20060269942A1 (de)
EP (1) EP1875239B1 (de)
JP (1) JP4790012B2 (de)
KR (1) KR100973156B1 (de)
AT (1) ATE527542T1 (de)
CA (1) CA2606477C (de)
DK (1) DK1875239T3 (de)
ES (1) ES2375495T3 (de)
WO (1) WO2006116736A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071718B2 (en) 2004-12-22 2011-12-06 General Electric Company Selective radiolabeling of biomolecules
CA2617907A1 (en) 2005-08-05 2007-02-15 Syntarga B.V. Triazole-containing releasable linkers and conjugates comprising the same
EP2013624B1 (de) 2006-03-14 2011-08-03 Universität Basel Verfahren zur identifizierung neuer leitverbindungen für arzneistoffkandidaten
US20100022481A1 (en) * 2006-08-02 2010-01-28 Dong Wang Drug Carriers, Their Synthesis, and Methods of Use Thereof
WO2008124703A2 (en) * 2007-04-05 2008-10-16 Siemens Medical Solutions Usa, Inc. Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
BRPI0906797A2 (pt) 2008-01-09 2015-07-14 Molecular Insight Pharm Inc Inibidores de anidrase carbônica ix
WO2009105746A2 (en) * 2008-02-22 2009-08-27 University Of South Florida Triazoles and processes for producing the same
AU2009259987B2 (en) * 2008-06-18 2015-08-27 California Institute Of Technology Multi-ligand capture agents and related compositions, methods and systems
US8618297B2 (en) 2008-07-25 2013-12-31 Basf Se Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions
WO2010051530A2 (en) 2008-10-31 2010-05-06 The General Hospital Corporation Compositions and methods for delivering a substance to a biological target
EP2706057B1 (de) 2008-12-05 2016-04-20 Molecular Insight Pharmaceuticals, Inc. Bis(imidazolyl)verbindungen and Radionuclidkomplexe
US8435488B2 (en) * 2009-02-27 2013-05-07 Genentech, Inc. Methods and compositions for protein labelling
CA2756137C (en) 2009-03-23 2015-11-24 Siemens Medical Solutions Usa, Inc. Imaging agents for detecting neurological disorders
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
BR112012000210A2 (pt) 2009-06-15 2019-09-24 Molecular Insight Pharm Inc processo para a produção de heterodímeoros de ácido glutâmico.
US10191060B2 (en) 2009-11-09 2019-01-29 University Of Washington Functionalized chromophoric polymer dots and bioconjugates thereof
WO2012074840A2 (en) 2010-11-22 2012-06-07 The General Hospital Corporation Compositions and methods for in vivo imaging
EP2966061B1 (de) 2011-03-04 2017-05-03 Life Technologies Corporation Verbindungen und verfahren zur konjugation von biomolekülen
WO2012121746A2 (en) 2011-03-09 2012-09-13 The General Hospital Corporation Imaging beta cell mass
US10796494B2 (en) 2011-06-06 2020-10-06 Microsoft Technology Licensing, Llc Adding attributes to virtual representations of real-world objects
WO2013103813A1 (en) 2012-01-06 2013-07-11 Molecular Insight Pharmaceuticals Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase ix
BR112015003729A2 (pt) 2012-08-24 2018-06-05 Univ Texas composto de fórmula estrutural i; composição farmacêutica; método de tratamento de uma doença mediada por caminho do hif; método de tratamento de uma doença causada por proliferação anormal de células; e método para alcançar um efeito em um paciente
EP2888253A4 (de) * 2012-08-24 2016-01-06 Univ Texas Heterocyclische hif-aktivitätsmodulatoren zur behandlung von krankheiten
WO2014065860A1 (en) 2012-10-24 2014-05-01 The General Hospital Corporation Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
CA2897437C (en) 2013-01-14 2021-12-14 Molecular Insight Pharmaceuticals, Inc. Triazine based radiopharmaceuticals and radioimaging agents
US10517965B2 (en) 2013-05-06 2019-12-31 The General Hospital Corporation Bioorthogonal turn-on probes
WO2015130790A2 (en) * 2014-02-25 2015-09-03 Board Of Regents, University Of Texas System Salts of heterocyclic modulators of hif activity for treatment of disease
WO2016085659A1 (en) * 2014-11-24 2016-06-02 Battelle Memorial Institute Chromatin activity precipitation method and system
WO2020084623A2 (en) * 2018-10-24 2020-04-30 Apa- Advanced Technologies Ltd. Fusogenic liposomes for selective imaging of tumor cells
CN112176418B (zh) * 2019-07-05 2024-11-29 中宏鑫投资控股(深圳)有限公司 高通量的化合物库构建和筛选方法以及反应装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3424525A1 (de) * 1984-07-04 1986-01-16 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zur herstellung von (pfeil hoch)1(pfeil hoch)(pfeil hoch)8(pfeil hoch)f-alkyl- und arylverbindungen durch halogenaustausch
US5519931A (en) * 1994-03-16 1996-05-28 Syncor International Corporation Container and method for transporting a syringe containing radioactive material
WO1996034853A1 (en) * 1995-05-01 1996-11-07 University Of Pittsburgh Azocompounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US6210655B1 (en) * 1997-06-18 2001-04-03 University Of Medicine & Dentistry Of Nj Site-specific 13C-enriched reagents for diagnostic medicine by magnetic resonance imaging
US6558903B1 (en) * 1999-06-30 2003-05-06 Millennium Pharmaceuticals, Inc. Kinases and uses thereof
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
US6808308B2 (en) * 2001-05-25 2004-10-26 Scanwell Systems Removable shielding for use during neurological examinations on a whole body pet scanner
AU2003228345B2 (en) * 2002-03-21 2009-02-05 Sunesis Pharmaceuticals, Inc. Identification of kinase inhibitors
ES2346646T5 (es) * 2002-05-30 2018-02-15 The Scripps Research Institute Ligación catalizada con cobre de azidas y acetilenos
WO2004057340A1 (en) * 2002-12-23 2004-07-08 Astex Technology Limited Synthesis and screening of ligands using x-ray crystallography
US20060067879A1 (en) * 2004-09-27 2006-03-30 Schuller Hildegard M Diagnosis of diseases associated with COX-2 expression

Also Published As

Publication number Publication date
WO2006116736A2 (en) 2006-11-02
WO2006116736A3 (en) 2007-02-01
KR20080003441A (ko) 2008-01-07
CA2606477A1 (en) 2006-11-02
KR100973156B1 (ko) 2010-07-30
JP2008541014A (ja) 2008-11-20
EP1875239B1 (de) 2011-10-05
JP4790012B2 (ja) 2011-10-12
EP1875239A2 (de) 2008-01-09
US20060269942A1 (en) 2006-11-30
CA2606477C (en) 2013-05-28
DK1875239T3 (da) 2012-01-23
ES2375495T3 (es) 2012-03-01

Similar Documents

Publication Publication Date Title
ATE527542T1 (de) Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie
ATE474938T1 (de) Verfahren zur erhöhung der genauigkeit einer nukleinsäuresequenzierung
WO2007053358A3 (en) Methods for identifying compounds of interest using encoded libraries
Mizukami et al. Aquatic decomposition of mammalian corpses: a forensic proteomic approach
DE602006019206D1 (de) Verfahren zur diagnose von multipler sklerose
ATE515488T1 (de) Click-chemie zur herstellung von reportermolekülen
DK2336315T3 (da) Fremgangsmåde til enzymatisk kodning ved effektiv syntese af store biblioteker
WO2004087308A8 (en) Method of synthesis and testing of combinatorial libraries using microcapsules
ATE388228T1 (de) Verfahren zur verknüpfung interessierender sequenzen
EP2258870A3 (de) Methode zur Identifizierung an ein biologische Zielmolekül bindende Verbindungen
DE602005022830D1 (de) Weniger immunogene bindungsmoleküle
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
DK1187933T3 (da) Betalactam-indeholdende forbindelser
WO2009117524A3 (en) Sparse matrix system and method for identification of specific ligands or targets
WO2005000875A3 (en) Compositions and methods comprising a ligand of chemerin receptor
Ai et al. Rhodium-catalyzed carbonylative coupling of alkyl halides with thiols: a radical process faster than easier nucleophilic substitution
WO2009064006A1 (ja) γ-セクレターゼの新規基質EphA7を利用したスクリーニング方法
de Jesus Cortez et al. Disulfide-trapping identifies a new, effective chemical probe for activating the nuclear receptor human LRH-1 (NR5A2)
Lirag et al. Four acid-catalysed dehydration reactions proceed without interference
WO2006091216A3 (en) Target-specific compomers and methods of use
WO2009090269A8 (en) Markers and diagnostic methods for metastasis
DE502005008867D1 (de) Verfahren zur herstellung von 2,5-dimethylphenylessigsäure
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
ATE478964T1 (de) Sonde zur diagnose von marfans-syndrom sowie verfahren zum screening mit der sonde

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties